Shenzhen GeneMind Biosciences Co., Ltd, a health tech firm that delivers gene sequencing tools for clinical applications, announced on Wednesday that it has garnered 410 million yuan ($64 million) in a Series B+ round of financing.
Continue reading with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
